C. Mathers and D. Loncar, Projections of global mortality and burden of disease from, PLoSmed, vol.3, issue.11, p.442, 2002.

L. Bry, P. Chen, and D. Sacks, Effect of hémoglobin variants and chemically modified derivatives on assays for glycohemoglobin, Clin chem, vol.47, pp.153-63, 2001.

S. Jeffcoat, Diabetes control and complications: the role of glycated haemoglobin, 25 years on, Diabetic Medicine, vol.323, issue.7, pp.657-65, 2004.
DOI : 10.1001/jama.280.17.1490

A. Yahia, . Diabete, and . Ramadan, Journée de fmc regionale Bejaïa, 29 Juin, 2013.

E. The and . Group, A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan (EPIDIAR) study. Diabetes Care, pp.2306-2317, 2004.

A. , M. Assaad-khalil, S. Buse, and J. , Recommendations for Management of Diabetes during Ramadan, update 2010, Diabetes Care, vol.33, issue.8, p.1895, 2010.

K. Faruque-pathan-md, R. Sahay, H. Zargar, A. , A. Ganie et al., South Asian Guidelines for management of endocrine disorders in ramadan, Indian Journal Endocrinol Metab, vol.16, issue.4, pp.499-502, 2012.

K. Bouhout, Evolution de l'hémoglobine glyquée au cours du jeûne du mois de ramadan chez les diabétiques de type 2 traités par antidiabétiques oraux. Faculté de médecine de Tours, 2008.

M. Lalande, . Diabète, and . Ramadan, Epid92-APLSG/réseau diabète92. 28 sept, 2006.

N. Olgun, The effect of Ramadan fasting on well-being and attitudes toward diabetes in patients with diabetes, European Diabetes Nursing, vol.67, issue.1, pp.79-85, 2006.
DOI : 10.1002/pdi.767

M. Cesur, D. Corapcioglu, A. Gursoy, S. Gonen, M. Ozduman et al., A comparaison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during ramadan fasting. Diabetes research and clinical practice, pp.141-147, 2007.

M. Procopiou, Hémoglobine glyquée: mise au point et nouveautés, Revue Médicale Suisse, issue.68, 2006.